In this issue of Neuron, Weng et al. (2017) reveal a role for active DNA demethylation in allowing axon regeneration to occur in the mature nervous system following axonal injury.
Axon outgrowth is a vital process that occurs primarily in the developing nervous system and requires the coordinated activation of pro-generative gene transcription programs in response to external stimuli (Zhou and Snider, 2006) . Upon neuronal differentiation, many progenerative genes become methylated and experience transcriptional silencing. Thus, DNA methylation serves as a barrier to impede widespread axonal growth in mature neurons. Remarkably, mature neurons can override this and other barriers to axonal growth in cases of injury. In the peripheral nervous system (PNS), for example, dorsal root ganglia have been shown to undergo long-distance regeneration and considerable functional recovery following axonal injury (Huebner and Strittmatter, 2009) .
Understanding the mechanisms that contribute to axon regeneration is of great clinical importance. Many recent studies have focused on the role of cell signaling pathways in promoting axon regeneration (Tedeschi and Bradke, 2017) . While highly relevant, such signaling mechanisms ignore the reduced intrinsic growth capacity of mature neurons. Epigenetic processes, such as DNA methylation and other chromatin modifications, are believed to be largely responsible for establishing a reduced capacity for growth in the mature nervous system. The underlying mechanisms that allow a neuron to override intrinsic impediments to growth in response to axonal injury are not well defined. In line with this reasoning, Weng, An, Cassin, and colleagues seek out and uncover an epigenetic mechanism that contributes to axon regeneration in the mature nervous system. Their findings suggest that active DNA demethylation, which is stimulated upon axonal injury, is necessary for proper axon regeneration and may act to de-repress critical pro-regenerative genes (Weng et al., 2017 ; Figure 1) . Weng et al. (2017) began by utilizing an in vivo system of sciatic nerve lesion (SNL) in the adult dorsal root ganglia (DRG) neurons of mice to probe for epigenetic factors that are upregulated following axonal injury. DRG contain the cell bodies of sensory neurons and are therefore an excellent model of peripheral nerve injury. Interestingly, the authors found upregulation of Tet Methylcytosine Dioxygenase 3 (Tet3) in neurons following injury. Tet3 is known to catalyze the conversion of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC), thereby initiating the process of active DNA demethylation. The observed increase in Tet3 expression was accompanied by an increase in the 5hmC mark, which is viewed as an intermediate product specifying partial DNA demethylation (Kohli and Zhang, 2013) . The authors showed that increases in 5hmC were indeed due to Tet3 upregulation by reducing Tet3 levels using a short hairpin RNA. As anticipated, reducing Tet3 levels in the context of SNL abolished the injury-induced increase in 5hmC.
Because DNA methylation is a robust transcriptional repressor (Kohli and Zhang, 2013) , active demethylation often coincides with increased transcription. Thus, the authors tested the hypothesis that injury-induced upregulation of Tet3 ultimately leads to increased transcription of key regeneration-associated genes (RAGs). Many genes, including Atf3, c-Myc, Smad1, and Stat3, are known to be upregulated following axonal lesion. For the majority of the study, the authors focused on Atf3 because it is one of the most robustly induced genes following SNL. While the Atf3 gene product is barely detectable in naive DRG neurons, it is significantly upregulated after injury. Importantly, Atf3's upregulation following SNL is greatly attenuated upon Tet3 knockdown, suggesting that Tet3 aids in regulating its expression. Because injury-induced transcriptional programs consist of many RAGs, the current observations are limited in scope. This is especially true given that the transcriptional regulation of other RAGs (such as Smad1 and Stat3) by Tet3 is less straightforward due to their relatively high basal levels of expression.
Having established that Tet3 is a component of the transcriptional program initiated upon SNL, the authors focused on examining its role in functional regeneration. In control cases, less than 20% of neurons typically fail to extend axons following SNL. While no baseline differences were observed after Tet3 knockdown, over 45% of Tet3-knockdown neurons failed to extend axons following injury. Additionally, almost twice as many neurons were able to extend long-distance projections in control cases compared to Tet3-knockdown cases. Finally, Tet3-knockdown neurons showed significantly reduced innervation into epidermal layers 3 weeks after the initial lesion. These differences were not mediated by differences in cell death. Together, these observations demonstrate the critical involvement of Tet3 in initiating robust axonal regeneration following SNL.
Thus far, Weng, An, Cassin, and colleagues have shown that Tet3 is upregulated following SNL and that it is required for proper axon regeneration and innervation following injury. Upstream of axon regeneration, Tet3 is required for the induced expression of key RAGs, such as Atf3. This observation, along with increased levels of 5hmC following injury, prompted the authors to test the hypothesis that Tet3 initiates DNA demethylation at loci specific to pro-regenerative genes. They found that CG methylation was significantly reduced in gene body and enhancer regions of Atf3 following injury. However, no significant change in methylation was observed when Tet3 levels were reduced concomitantly. Tet3 chromatin immunoprecipitation revealed increased Tet3 binding at the Atf3 gene following SNL, supporting the notion of enhanced Tet3 activity at Atf3 loci following injury.
DNA demethylation is not completed by Tet3 alone. Thymine DNA glycosylase (Tdg) makes use of the base excision repair pathway downstream of 5hmC to generate an unmodified cytosine, thereby completing the DNA demethylation process (Kohli and Zhang, 2013) . The authors confirmed that complete DNA demethylation is required for proper axon regeneration by reducing levels of Tdg in DRG neurons using a conditional Tdg knockout mouse. Tdg knockdown resulted in an attenuation of Atf3 induction as well as reduced axon regeneration; this was comparable to the effects of knocking down Tet3 during axon injury. However, it is surprising that Tdg levels are not elevated following injury in a similar fashion to Tet3.
While axon regeneration is much more robust in the PNS than in the central nervous system (CNS), recent findings suggest that CNS axon regeneration is indeed possible (Kurimoto et al., 2010) . The authors attempted to extend their findings to the CNS using a model of PTEN deletion, which enhances the regenerative ability of adult CNS neurons (Park et al., 2008) . Remarkably, they showed that, in the context of PTEN deletion, knocking down Tet1 (but not Tet3) in retinal ganglion cells is sufficient to attenuate axon regeneration. The extension of these findings to CNS neurons suggests that DNA demethylation may have a general pro-regenerative role in adult neurons following injury. However, the specific involvement of Tet1 in the CNS and Tet3 in the PNS remains unexplored. Potential mechanistic differences between CNS and PNS neurons are especially relevant, given the significantly reduced ability of CNS neurons to regenerate axons following injury.
The work presented in this manuscript describes an epigenetic mechanism that is initiated upon axonal injury to aid in the process of regeneration. It suggests that axonal lesions may stimulate the upregulation of Tet3, which is then able to promote the active demethylation of critical pro-regenerative genes. However, the upstream signal that triggers this response is still largely unknown. In this work, the authors provide preliminary evidence that retrograde calcium signaling from injured axons may induce Tet3 expression by showing that the use of a calcium chelator at the time of injury attenuates Tet3 upregulation. This is promising; however, further experiments are needed to confirm this interpretation. Upon sciatic nerve lesion or other type of axon injury, retrograde calcium signaling likely initiates the process of active DNA demethylation within the nuclei of injured neurons. Tet3 (red), which catalyzes the conversion of 5mC to 5hmC, works in concert with Tdg (orange) to complete the demethylation process. Weng et al. (2017) provide evidence that Tet3 levels increase after axon injury and that both Tet3 and Tdg are required for proper axon regeneration. They propose that, upon axon injury, Tet3 and Tdg demethylate regeneration-associated genes, ultimately increasing their expression. This mechanism allows mature neurons to regain the capacity for growth in cases of injury.
Similarly, the full extent of epigenetic regulation that occurs in response to axonal injury remains unknown. While the authors show significant regeneration impairments following Tet3 knockdown, axon regeneration was not entirely abolished. This indicates that additional regulatory mechanisms are indeed at play in the injured neuron. Moreover, the approach taken by Weng et al. (2017) was very targeted: a limited number of epigenetic factors were initially considered, several genes known to be involved in DNA demethylation did not show expression changes following injury, and very few RAGs were probed following the identification of Tet3 as a critical mediator of regeneration. Future work on this topic should consider more unbiased approaches. Specifically, whole-genome bisulphite sequencing following SNL would provide a more comprehensive picture of the effects that axonal injury has on the methylome and potentially shed light on the additional factors that provide proregenerative specificity. Additionally, future studies should test the ability to enhance normal levels of axon regeneration by manipulating the activity of Tet3. These experiments will have far-reaching implications for regenerative medicine in both the PNS and CNS. Given the inherent differences in the capacities for growth of PNS and CNS neurons, identifying the differences between PNS and CNS neurons' epigenetic response to injury in the absence of genetic mutations may provide insight. While further efforts are required for a more complete understanding of the epigenetic mechanisms that respond to axonal injury and regeneration, the current work by Weng, An, Cassin, and colleagues provides a strong basis for such understanding.
